Press release
Sepsis Diagnostics Market Trends, Future Outlook, COVID-19 Impact Analysis, Forecast 2022-2028
The global sepsis diagnostics market is estimated to grow at a significant CAGR during the forecast period. Sepsis is a major unmet medical need caused by a patient's overwhelming and life-threatening immune response to infection and can lead to tissue damage, organ failure, and even death. Sepsis affects an estimated 20-30 million people globally every year. According to the Agency for Healthcare Research and Quality, sepsis is the most expensive condition treated in US hospitals, costing more than $20 billion and increasing annually on average by 11.9%.
A full report of Sepsis Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/sepsis-diagnostics-market
The key players operating in the global sepsis diagnostics market is also driving the market growth. Players such as Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others are significantly contributing to the sepsis diagnostics industry growth by adopting various growth strategies. Product launches & developments, partnerships, agreements, and acquisitions are among some of the strategies adopted by the players to sustain in a competitive sepsis diagnostics market globally, during the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sepsis-diagnostics-market
In April 2019, the Scottish Government along with FEAT - The Fiona Elizabeth Agnew Trust, Sepsis Research center started a campaign across Scotland to create public awareness regarding signs and symptoms of sepsis.
In April 2019, the US FDA approved Beckman Coulter Inc., a Danaher Corp. company for its Early Sepsis Indicator. This indicator is a cellular biomarker designed and enables the identification of patients with sepsis or at high risk of developing the disease.
In August 2018, Sysmex Corp., a Japan-based company introduced its new HISCL Presepsin Assay Kit, for the detection of presepsin, the primary test parameter for bacterial sepsis. This kit aid in the early diagnosis of bacterial sepsis with higher accuracies in comparison with conventional biomarkers.
In May 2018, the US FDA approved T2 Biosystems, Inc., a US-based emerging medical examination solutions company for its T2Bacteria Panel. The novel developed panel is intended for the recognition of specific sepsis-causing bacterial pathogens in human whole blood specimens.
In March 2018, Biocartis Group NV, a molecular diagnostics company and Immunexpress Pty Ltd, a host response molecular diagnostic company, committed to improving clinical and economic outcomes for suspected sepsis patients, today announced that they have entered into a partnership agreement aimed at the development and commercialization of Immunexpress' SeptiCypte test for use on Biocartis' sample-to-result Idylla platform.
In October 2017, the US FDA approved bioMérieux SA for its BacT/ALERT VIRTUO fully automated blood culture system. Further, in January 2017, Bruker acquired InVivo Biotech Services GmbH, a Germany based company for the expansion of its microbiology assay menu for its MALDI Biotyper platform.
Global Sepsis Diagnostics Market - Segmentation
By Product Type
• Instruments
• Assays and Reagents
• Other Products
By Technology
• Molecular Diagnostics
• Immunoassay
• Others
By Pathogen
• Bacterial Sepsis Diagnostics
• Fungal Sepsis Diagnostics
• Others
Sepsis Diagnostics Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Abbott Laboratories, Inc.
• Abionic SA
• Accelerate Diagnostics, Inc.
• Becton, Dickinson & Co.
• Biomérieux SA
• Bruker Corp.
• Cepheid Inc.
• Danaher Corp.
• EKF Diagnostics Holdings plc
• F. Hoffmann-La Roche Ltd.
• Immunexpress Inc.
• Inflammatix, Inc.
• Luminex Corp.
• Nan?mix, Inc.
• Qiagen NV
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
A full report of Sepsis Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/sepsis-diagnostics-market
The key players operating in the global sepsis diagnostics market is also driving the market growth. Players such as Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others are significantly contributing to the sepsis diagnostics industry growth by adopting various growth strategies. Product launches & developments, partnerships, agreements, and acquisitions are among some of the strategies adopted by the players to sustain in a competitive sepsis diagnostics market globally, during the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sepsis-diagnostics-market
In April 2019, the Scottish Government along with FEAT - The Fiona Elizabeth Agnew Trust, Sepsis Research center started a campaign across Scotland to create public awareness regarding signs and symptoms of sepsis.
In April 2019, the US FDA approved Beckman Coulter Inc., a Danaher Corp. company for its Early Sepsis Indicator. This indicator is a cellular biomarker designed and enables the identification of patients with sepsis or at high risk of developing the disease.
In August 2018, Sysmex Corp., a Japan-based company introduced its new HISCL Presepsin Assay Kit, for the detection of presepsin, the primary test parameter for bacterial sepsis. This kit aid in the early diagnosis of bacterial sepsis with higher accuracies in comparison with conventional biomarkers.
In May 2018, the US FDA approved T2 Biosystems, Inc., a US-based emerging medical examination solutions company for its T2Bacteria Panel. The novel developed panel is intended for the recognition of specific sepsis-causing bacterial pathogens in human whole blood specimens.
In March 2018, Biocartis Group NV, a molecular diagnostics company and Immunexpress Pty Ltd, a host response molecular diagnostic company, committed to improving clinical and economic outcomes for suspected sepsis patients, today announced that they have entered into a partnership agreement aimed at the development and commercialization of Immunexpress' SeptiCypte test for use on Biocartis' sample-to-result Idylla platform.
In October 2017, the US FDA approved bioMérieux SA for its BacT/ALERT VIRTUO fully automated blood culture system. Further, in January 2017, Bruker acquired InVivo Biotech Services GmbH, a Germany based company for the expansion of its microbiology assay menu for its MALDI Biotyper platform.
Global Sepsis Diagnostics Market - Segmentation
By Product Type
• Instruments
• Assays and Reagents
• Other Products
By Technology
• Molecular Diagnostics
• Immunoassay
• Others
By Pathogen
• Bacterial Sepsis Diagnostics
• Fungal Sepsis Diagnostics
• Others
Sepsis Diagnostics Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Abbott Laboratories, Inc.
• Abionic SA
• Accelerate Diagnostics, Inc.
• Becton, Dickinson & Co.
• Biomérieux SA
• Bruker Corp.
• Cepheid Inc.
• Danaher Corp.
• EKF Diagnostics Holdings plc
• F. Hoffmann-La Roche Ltd.
• Immunexpress Inc.
• Inflammatix, Inc.
• Luminex Corp.
• Nan?mix, Inc.
• Qiagen NV
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
